  Biomaterial systems have allowed for the in vitro production of complex,
emergent tissue behaviors that were not possible with conventional 2D culture
systems allowing for analysis of the normal development as well as disease
processes. We propose that the path towards developing the design parameters
for biomaterial systems lies with identifying the molecular drivers of emergent
behavior through leveraging technological advances in systems biology,
including single cell omics, genetic engineering, and high content imaging.
This research focus, which we term systems tissue engineering, can uniquely
interrogate the mechanisms by which complex tissue behaviors emerge with the
potential to capture the contribution of i) dynamic regulation of tissue
development and dysregulation, ii) single cell heterogeneity and the function
of rare cell types, and iii) the spatial distribution and structure of
individual cells and cell types within a tissue. Collectively, systems tissue
engineering can facilitate the identification of biomaterial design parameters
that will accelerate basic science discovery and translation.
